FDA and DEA call on AD­HD drug man­u­fac­tur­ers to up pro­duc­tion amid on­go­ing short­ages

Last year
FDA+
Manufacturing

BAR­DA awards Emer­gent 10-year, $704M con­tract for Ebo­la treat­ment

Last year
Deals
Manufacturing

Hu­mi­ra and Ste­lara con­tin­ue to lead spe­cial­ty drug spend­ing, but new­er drugs like Keytru­da, Skyrizi are clos­ing in ...

Last year
Pharma
Marketing

Can the Bar­bie movie's spot­light on women’s is­sues spill over to phar­ma mar­ket­ing and health­care? Agency says yes

Last year
Pharma
Marketing

Mar­ket­ingRx roundup: Mil­len­ni­als warm up to phar­ma ads; Astel­las, Seagen add to blad­der can­cer cam­paign

Last year
Pharma
Marketing

In­ovio prunes head­count again; Au­los adds to Se­ries A

Last year
News Briefing

With Covid rev­enues falling, Pfiz­er lays out growth plans and pos­si­ble cost cuts

Last year
Pharma

Bio­Marin touts Vox­zo­go sales bump in Q2 re­sults, notes 'tem­porar­i­ly tight sup­ply'

Last year
Pharma
Manufacturing

Long­wood launch­es start­up Solu with drug can­di­dates from GSK and $31M to start

Last year
Financing
Startups

TG Ther­a­peu­tics signs $645M deal to kick-start in­ter­na­tion­al launch of MS an­ti­body 

Last year
Deals

Up­dat­ed: EQRx sells it­self to an­oth­er Alex­is Borisy com­pa­ny, Rev­o­lu­tion Med­i­cines, in all-stock deal

Last year
Deals

Up­dat­ed: Mer­ck Q2 earn­ings pro­pelled by Keytru­da, Gar­dasil sales, but ex­pects 's­low­er' growth for HPV vac­cine

Last year
Pharma

Bris­tol My­ers, As­traZeneca strike $510M set­tle­ment on PD-L1, CT­LA-4 patent law­suits

Last year
Pharma
Law

PureTech Health snags $11.4M from DOD to test hor­mone drug in rare brain dis­ease

Last year
Financing

Failed tri­als for 16 IGF-1R in­hibitors and $1.6B lat­er: Time for bet­ter pre­clin­i­cal mod­els?

Last year
R&D

PDU­FA VII: Drug ap­pli­ca­tion fees in­crease by 25% in first year of new five-year deal

Last year
FDA+

FDA looks to work with more out­side agen­cies for in­spec­tions as it en­ters in­to an agree­ment for in­spec­tions with ...

Last year
Pharma
FDA+

US gov­ern­ment OK with com­bin­ing brief­ing sched­ule from Bris­tol My­ers, J&J in IRA fight

Last year
Pharma
Law

Vi­a­tris launch­es gener­ic for As­traZeneca's asth­ma and COPD drug Sym­bi­cort

Last year
Pharma

FDA ap­proves GSK's Jem­per­li for front­line use in cer­tain ad­vanced en­dome­tri­al can­cers

Last year
FDA+

Pur­due Phar­ma is in the spot­light again with new Net­flix spe­cial amid fed­er­al chal­lenge to its bank­rupt­cy agree­ment

Last year
Marketing
Law

A deal? An as­set sale? A launch? Every­one is watch­ing next moves for Roivant, Bridge­Bio

Last year
Deals
Pharma

An­nex­on lays out more GA drug da­ta; Okyo Phar­ma pulls back pub­lic of­fer­ing

Last year
News Briefing

Pe­ter Hecht’s $81M pledge to sal­vage Cy­cle­ri­on as­sets nabs Po­laris sup­port

Last year
Financing
Startups
First page Previous page 303304305306307308309 Next page Last page
A service from the Financial Times